{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:46:50Z","timestamp":1770688010316,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11883-008-0019-x","type":"journal-article","created":{"date-parts":[[2008,4,5]],"date-time":"2008-04-05T08:27:10Z","timestamp":1207384030000},"page":"128-133","source":"Crossref","is-referenced-by-count":71,"title":["Rheumatoid arthritis and cardiovascular disease"],"prefix":"10.1007","volume":"10","author":[{"given":"Saurabh S.","family":"Dhawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshed A.","family":"Quyyumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,6]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","volume":"27","author":"S.E. Gabriel","year":"2001","unstructured":"Gabriel SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001, 27:269\u2013281.","journal-title":"Rheum Dis Clin North Am"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","volume":"46","author":"S. Doornum Van","year":"2002","unstructured":"Van Doornum S, McColl G, Wicks IP: Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002, 46:862\u2013873.","journal-title":"Arthritis Rheum"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/ard.49.6.363","volume":"49","author":"P.A. Reilly","year":"1990","unstructured":"Reilly PA, Cosh JA, Maddison PJ, et al.: Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990, 49:363\u2013369.","journal-title":"Ann Rheum Dis"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","volume":"37","author":"F. Wolfe","year":"1994","unstructured":"Wolfe F, Mitchell DM, Sibley JT, et al.: The mortality of rheumatoid arthritis. Arthritis Rheum 1994, 37:481\u2013494.","journal-title":"Arthritis Rheum"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","volume":"65","author":"D.H. Solomon","year":"2006","unstructured":"Solomon DH, Goodson NJ, Katz JN, et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006, 65:1608\u20131612.","journal-title":"Ann Rheum Dis"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"D.H. Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303\u20131307.","journal-title":"Circulation"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H. Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Crowson CS, Nicola PJ, et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402\u2013411.","journal-title":"Arthritis Rheum"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","volume":"54","author":"P.J. Nicola","year":"2006","unstructured":"Nicola PJ, Crowson CS, Maradit-Kremers H, et al.: Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006, 54:60\u201367.","journal-title":"Arthritis Rheum"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"P.J. Nicola","year":"2005","unstructured":"Nicola PJ, Maradit-Kremers H, Roger VL, et al.: The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005, 52:412\u2013420.","journal-title":"Arthritis Rheum"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/ard.59.3.227","volume":"59","author":"M. Franco Di","year":"2000","unstructured":"Di Franco M, Paradiso M, Mammarella A, et al.: Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis 2000, 59:227\u2013229.","journal-title":"Ann Rheum Dis"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2005.05.003","volume":"35","author":"M.A. Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J: The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease. Sem Arthritis Rheum 2005, 35:132\u2013133.","journal-title":"Sem Arthritis Rheum"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"I.D. Rincon del","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, et al.: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737\u20132745.","journal-title":"Arthritis Rheum"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","volume":"50","author":"D.H. Solomon","year":"2004","unstructured":"Solomon DH, Curhan GC, Rimm EB, et al.: Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004, 50:3444\u20133449.","journal-title":"Arthritis Rheum"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","volume":"165","author":"A. Escalante","year":"2005","unstructured":"Escalante A, Haas RW, del Rincon I: Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005, 165:1624\u20131629.","journal-title":"Arch Intern Med"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N. Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB: Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957\u20132963.","journal-title":"Circulation"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","volume":"44","author":"E. Hurt-Camejo","year":"2001","unstructured":"Hurt-Camejo E, Paredes S, Masana L, et al.: Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile [see comment]. Arthritis Rheum 2001, 44:2761\u20132767.","journal-title":"Arthritis Rheum"},{"key":"19_CR17","first-page":"1701","volume":"26","author":"Y.B. Park","year":"1999","unstructured":"Park YB, Lee SK, Lee WK, et al.: Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999, 26:1701\u20131704.","journal-title":"J Rheumatol"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","volume":"54","author":"M. McMahon","year":"2006","unstructured":"McMahon M, Grossman J, FitzGerald J, et al.: Proin-flammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54:2541\u20132549.","journal-title":"Arthritis Rheum"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1194\/jlr.M600414-JLR200","volume":"48","author":"M. Tabuchi","year":"2007","unstructured":"Tabuchi M, Inoue K, Usui-Kataoka H, et al.: The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 2007, 48:768\u2013781.","journal-title":"J Lipid Res"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","volume":"25","author":"D. Dursunolu","year":"2005","unstructured":"Dursunolu D, Evrengul H, Polat B, et al.: Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 2005, 25:241\u2013245.","journal-title":"Rheumatol Int"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1529-0131(199904)42:3<443::AID-ANR8>3.0.CO;2-Q","volume":"42","author":"Y. Asanuma","year":"1999","unstructured":"Asanuma Y, Kawai S, Aoshima H, et al.: Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis [see comment]. Arthritis Rheum 1999, 42:443\u2013447.","journal-title":"Arthritis Rheum"},{"key":"19_CR22","first-page":"252","volume":"32","author":"M. Vis","year":"2005","unstructured":"Vis M, Nurmohamed MT, Wolbink G, et al.: Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J Rheumatol 2005, 32:252\u2013255.","journal-title":"J Rheumatol"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03009740500474578","volume":"35","author":"S.R. Dahlqvist","year":"2006","unstructured":"Dahlqvist SR, Engstrand S, Berglin E, Johnson O: Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy. Scand J Rheumatol 2006, 35:107\u2013111.","journal-title":"Scand J Rheumatol"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/0026-0495(91)90064-4","volume":"40","author":"G. Paolisso","year":"1991","unstructured":"Paolisso G, Valentini G, Giugliano D, et al.: Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metab Clin Exp 1991, 40:902\u2013907.","journal-title":"Metab Clin Exp"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar428","volume":"4","author":"P.H. Dessein","year":"2002","unstructured":"Dessein PH, Stanwix AE, Joffe BI: Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and highdensity lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002, 4:R5.","journal-title":"Arthritis Res"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"G.S. Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, et al.: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95:2409\u20132415.","journal-title":"J Clin Invest"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/CIRCRESAHA.107.152165","volume":"100","author":"C.P. Liang","year":"2007","unstructured":"Liang CP, Han S, Senokuchi T, Tall AR: The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res 2007, 100:1546\u20131555.","journal-title":"Circ Res"},{"key":"19_CR28","first-page":"83","volume":"24","author":"M.A. Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, et al.: Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:83\u201386.","journal-title":"Clin Exp Rheumatol"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V74.1.165.165","volume":"74","author":"K.A. Bauer","year":"1989","unstructured":"Bauer KA, ten Cate H, Barzegar S, et al.: Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989, 74:165\u2013172.","journal-title":"Blood"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI117202","volume":"93","author":"D. Kirchhofer","year":"1994","unstructured":"Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR: Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 1994, 93:2073\u20132083.","journal-title":"J Clin Invest"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.RES.87.2.126","volume":"87","author":"A.D. Schecter","year":"2000","unstructured":"Schecter AD, Spirn B, Rossikhina M, et al.: Release of active tissue factor by human arterial smooth muscle cells [see comment]. Circ Res 2000, 87:126\u2013132.","journal-title":"Circ Res"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R. Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K, et al.: Hyperhomocysteinemia: an independent risk factor for vascular disease [see comment]. N Engl J Medicine 1991, 324:1149\u20131155.","journal-title":"N Engl J Medicine"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/art.1780400418","volume":"40","author":"R. Roubenoff","year":"1997","unstructured":"Roubenoff R, Dellaripa P, Nadeau MR, et al.: Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997, 40:718\u2013722.","journal-title":"Arthritis Rheum"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9343(02)01528-0","volume":"114","author":"E.-P. Chiang","year":"2003","unstructured":"Chiang E-PI, Bagley PJ, Selhub J, et al.: Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 2003, 114:283\u2013287.","journal-title":"Am J Med"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"R1404","DOI":"10.1186\/ar1839","volume":"7","author":"E.-P. Chiang","year":"2005","unstructured":"Chiang E-PI, Selhub J, Bagley PJ, et al.: Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther 2005, 7:R1404\u2013R1411.","journal-title":"Arthritis Res Ther"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/ard.62.7.694","volume":"62","author":"P.E. Lazzerini","year":"2003","unstructured":"Lazzerini PE, Capecchi PL, Bisogno S, et al.: Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 2003, 62:694\u2013695.","journal-title":"Ann Rheum Dis"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"A.E. Ede van","year":"2002","unstructured":"van Ede AE, Laan RF, Blom HJ, et al.: Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology 2002, 41:658\u2013665.","journal-title":"Rheumatology"},{"key":"19_CR38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R. Ross","year":"1999","unstructured":"Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115\u2013126.","journal-title":"N Engl J Med"},{"key":"19_CR39","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","volume":"100","author":"V. Pasceri","year":"1999","unstructured":"Pasceri V, Yeh ET: A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124\u20132126.","journal-title":"Circulation"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","volume":"101","author":"G. Liuzzo","year":"2000","unstructured":"Liuzzo G, Goronzy JJ, Yang H, et al.: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000, 101:2883\u20132888.","journal-title":"Circulation"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","volume":"109","author":"R. Gerli","year":"2004","unstructured":"Gerli R, Schillaci G, Giordano A, et al.: CD4+CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004, 109:2744\u20132748.","journal-title":"Circulation"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1002\/art.21353","volume":"52","author":"E. Bryl","year":"2005","unstructured":"Bryl E, Vallejo AN, Matteson EL, et al.: Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis [see comment]. Arthritis Rheum 2005, 52:2996\u20133003.","journal-title":"Arthritis Rheum"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","volume":"349","author":"J.M. Kremer","year":"2003","unstructured":"Kremer JM, Westhovens R, Leon M, et al.: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003, 349:1907\u20131915.","journal-title":"N Engl J Med"},{"key":"19_CR44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"J.M. Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JPJ, et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593\u2013600.","journal-title":"N Engl J Med"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","volume":"111","author":"J. Grisar","year":"2005","unstructured":"Grisar J, Aletaha D, Steiner CW, et al.: Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005, 111:204\u2013211.","journal-title":"Circulation"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.22424","volume":"56","author":"A. Surdacki","year":"2007","unstructured":"Surdacki A, Martens-Lobenhoffer J, Wloch A, et al.: Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007, 56:809\u2013819.","journal-title":"Arthritis Rheum"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.lfs.2006.07.035","volume":"79","author":"J.N. Ablin","year":"2006","unstructured":"Ablin JN, Boguslavski V, Aloush V, et al.: Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006, 79:2364\u20132369.","journal-title":"Life Sci"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","volume":"106","author":"J.P. Halcox","year":"2002","unstructured":"Halcox JP, Schenke WH, Zalos G, et al.: Prognostic value of coronary vascular endothelial dysfunction [see comment]. Circulation 2002, 106:653\u2013658.","journal-title":"Circulation"},{"key":"19_CR49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","volume":"101","author":"V. Schachinger","year":"2000","unstructured":"Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899\u20131906.","journal-title":"Circulation"},{"key":"19_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.104.2.191","volume":"104","author":"F. Perticone","year":"2001","unstructured":"Perticone F, Ceravolo R, Pujia A, et al.: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001, 104:191\u2013196.","journal-title":"Circulation"},{"key":"19_CR51","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/01.CIR.0000028581.07992.56","volume":"106","author":"J.A. Vita","year":"2002","unstructured":"Vita JA, Keaney JF Jr: Endothelial function: a barometer for cardiovascular risk? [comment]. Circulation 2002, 106:640\u2013642.","journal-title":"Circulation"},{"key":"19_CR52","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/HJH.0b013e3280b0157e","volume":"25","author":"E. Arosio","year":"2007","unstructured":"Arosio E, De Marchi S, Rigoni A, et al.: Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis [see comment]. J Hypertens 2007, 25:1273\u20131278.","journal-title":"J Hypertens"},{"key":"19_CR53","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","volume":"22","author":"R. Bergholm","year":"2002","unstructured":"Bergholm R, Leirisalo-Repo M, Vehkavaara S, et al.: Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002, 22:1637\u20131641.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"19_CR54","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D. Hurlimann","year":"2002","unstructured":"Hurlimann D, Forster A, Noll G, et al.: Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002, 106:2184\u20132187.","journal-title":"Circulation"},{"key":"19_CR55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","volume":"36","author":"A.J. Littler","year":"1997","unstructured":"Littler AJ, Buckley CD, Wordsworth P, et al.: A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 1997, 36:164\u2013169.","journal-title":"Br J Rheumatol"},{"key":"19_CR56","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/ard.61.9.804","volume":"61","author":"P.A. Klimiuk","year":"2002","unstructured":"Klimiuk PA, Sierakowski S, Latosiewicz R, et al.: Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 2002, 61:804\u2013809.","journal-title":"Ann Rheum Dis"},{"key":"19_CR57","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.33.5.1111","volume":"33","author":"J. Blacher","year":"1999","unstructured":"Blacher J, Asmar R, Djane S, et al.: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999, 33:1111\u20131117.","journal-title":"Hypertension"},{"key":"19_CR58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/hy0102.099031","volume":"39","author":"P. Boutouyrie","year":"2002","unstructured":"Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10\u201315.","journal-title":"Hypertension"},{"key":"19_CR59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/art.10735","volume":"48","author":"S. Doornum Van","year":"2003","unstructured":"Van Doornum S, McColl G, Jenkins A, et al.: Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function [see comment]. Arthritis Rheum 2003, 48:72\u201380.","journal-title":"Arthritis Rheum"},{"key":"19_CR60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/art.10748","volume":"48","author":"M. Wong","year":"2003","unstructured":"Wong M, Toh L, Wilson A, et al.: Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003, 48:81\u201389.","journal-title":"Arthritis Rheum"},{"key":"19_CR61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","volume":"114","author":"K.M. Maki-Petaja","year":"2006","unstructured":"Maki-Petaja KM, Hall FC, Booth AD, et al.: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy [see comment]. Circulation 2006, 114:1185\u20131192.","journal-title":"Circulation"},{"key":"19_CR62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.STR.30.4.841","volume":"30","author":"S. Ebrahim","year":"1999","unstructured":"Ebrahim S, Papacosta O, Whincup P, et al.: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999, 30:841\u2013850.","journal-title":"Stroke"},{"key":"19_CR63","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","volume":"48","author":"I. Rincon Del","year":"2003","unstructured":"Del Rincon I, Williams K, Stern MP, et al.: Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48:1833\u20131840.","journal-title":"Arthritis Rheum"},{"key":"19_CR64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-144-4-200602210-00006","volume":"144","author":"M.J. Roman","year":"2006","unstructured":"Roman MJ, Moeller E, Davis A, et al.: Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Inter Med 2006, 144:249\u2013256.","journal-title":"Ann Inter Med"},{"key":"19_CR65","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"D.W. McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R, et al.: Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004, 363:2015\u20132021.","journal-title":"Lancet"},{"key":"19_CR66","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","volume":"50","author":"K.M. Maki-Petaja","year":"2007","unstructured":"Maki-Petaja KM, Booth AD, Hall FC, et al.: Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007, 50:852\u2013858.","journal-title":"J Am Coll Cardiol"},{"key":"19_CR67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","volume":"2","author":"N. Nishimoto","year":"2006","unstructured":"Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006, 2:619\u2013626.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"19_CR68","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"H.K. Choi","year":"2002","unstructured":"Choi HK, Hernan MA, Seeger JD, et al.: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002, 359:1173\u20131177.","journal-title":"Lancet"},{"key":"19_CR69","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ncprheum0178","volume":"2","author":"J.T. Giles","year":"2006","unstructured":"Giles JT, Post W, Blumenthal RS, Bathon JM: Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2006, 2:320\u2013329.","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-008-0019-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-008-0019-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-008-0019-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:09:13Z","timestamp":1588540153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-008-0019-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s11883-008-0019-x","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}